Since reduction in PPI can serve as a biomarker of schizophrenia [25], neurological deficits of Top3β KO mice suggest that our newly produced Top3β−/− mouse model might recapitulate symptoms of schizophrenia patients. Here, TOP3B is linked to schizophrenia.